Nature's Sunshine Products (NATR) vs Sol-Gel Technologies (SLGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sol-Gel Technologies (SLGL) has outperformed Nature's Sunshine Products (NATR) over the past year, gaining 78.9% versus a loss of 16.2%. Over five years, NATR leads with a -18.2% price change compared with -24.6% for SLGL. Sol-Gel Technologies is the larger company by market cap ($233.1 million vs $222.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NATR | SLGL |
|---|---|---|
| Share price | $12.66 | $71.19 |
| Market cap | $222.67M | $233.08M |
| 1-day change | +0.68% | +1.21% |
| YTD return | -41.75% | +66.92% |
| 1-year return | -16.20% | +78.89% |
| 5-year return | -18.22% | -24.57% |
| P/E ratio (TTM) | 12.53 | — |
| Forward P/E | 10.29 | — |
| EPS (TTM) | $1.01 | $-5.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.14 | $97.97 |
| 52-week low | $12.31 | $28.81 |
| Distance from 52-week high | -55.03% | -27.33% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +141.01% | +114.22% |
| Average volume | 160.23K | 55.55K |
| Shares outstanding | 17.60M | 3.27M |
| Employees | 806 | 28 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SLGL has outperformed NATR by 95.1 percentage points over the past year.
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
About Sol-Gel Technologies
SLGL stock →Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.
Health Care · Biotechnology: Pharmaceutical Preparations · 28 employees
NATR vs SLGL FAQ
Which is bigger, Nature's Sunshine Products or Sol-Gel Technologies?
Sol-Gel Technologies (SLGL) is larger, with a market capitalization of $233.08M compared with $222.67M for Nature's Sunshine Products (NATR).
Which stock has performed better over the past year, NATR or SLGL?
SLGL returned +78.89% over the past 12 months, compared with -16.20% for NATR (price return, excluding dividends). Past performance does not predict future results.
Are Nature's Sunshine Products and Sol-Gel Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.